cortisol, and 11-deoxycortisol were extracted with methylene chloride, separated by liquid chromatography, identified by their retention times, and quantitated by monitoring the absorbance at 254 nm.
The method is specific and sensitive to as little as 2.5 ng of 17a-hydroxyprogesterone.
Mean analytical recovery of added 17a-hydroxyprogesterone was 99% (SD 11%) and the CV for the same or different assays ranged from 3.5 to 9.4%. 6f3-Hydroxyprogesterone was used as the internal standard. Concentrations of 17a-hydroxypro-. gesterone in serum of normal men and women were <2.5
.tg/L, but women in the luteal phase of the menstrual cycle had higher values. Mean 17a-hydroxyprogesterone content in serum from mixed cord blood of normal newborns was 28.1 (SD 13.8) tg/L. Results by this method correlated well (r = 0.97) with results by radioimmunoassay, but were somewhat higher. 
Materials and Methods

Analytical methods.
The liquid-chromatographic method used to measure steroids in serum has been described in detail previously ( Serum was separated by centrifugation and stored at -20 #{176}C until assay.
Statistical methods.
Correlation between liquid chromatography and RIA was tested by linear correlation, and significance of differences between assays was assessed by paired t -test.
Results
17OHP was separated
by liquid chromatography, identified by its retention time, and quantitated by the height of the chromatographic peak. The retention time varied with the concentration of methanol used in the mobile phase; at a proportion (by vol) of 55/45 (methanol/water) it was 32.5 mm, and at 60/40 it was 21 mm.
Specificity. 17OHP was isolated and accurately quantitated in 139 of 143 serum samples tested; in four samples, an additional chromatographic peak interfered with its measurement. 17OHP was separated from cortisol, 11-deoxycortisol, and the internal standard, 6/3-hydroxyprogesterone, their respective retention times (in methanol/water, 55/45, by vol) being 10, 17, and 24 mm (Figures 1 and 2 ).
Sensitivity.
Amounts of 17OHP as low as 2.5 ng could be quantitated and the standard curve was linear up to a concentration of 160 ng (data not shown). 17OHP concentrations as low as 2.5 sg/L could be measured in 1 mL of human serum. 
Precision and accuracy.
Within-assay and between-assay variability were assessed in serum samples containing 3, 10, 30, 100, or 300 zg of 17OHP per liter added to a serum pool containing no detectable 17OHP. CV ranged from 3.9 to 9.4% in the same assay and from 3.5 to 8.3% in different assays (Table 1) .
Internal standard.
613-Hydroxyprogesterone, a steroid not found in serum but having physical and chemical characteristics similar to those of the steroids studied, was used as internal standard for this assay. Its retention time was close to that of cortisol, 11-deoxycortisol, and 17OHP (Figure 1) , and we were able to isolate and quantitate it in 183 of 187 serum samples to which it had been added before the extraction procedure.
Human studies.
The respective concentrations of I7OHP in serum of normal men and post-menopausal women were less than 2 g/L and 1 sg/L, and the values in the follicular and luteal phases of the menstrual cycle were 0 to 2.5 tg/L and 0 to 3.3 tg/L, respectively. 
Discussion
In this liquid-chromatographic method for isolating and quantitating 17OHP, we were able to separate 17OHP from cortisol and 11-deoxycortisol in the same serum sample. The assay was specific for 17OHP, we could accurately measure concentrations as low as 2.5 ig/L, the recovery of added 17OHP was about 100%, and the assay variability was less than 10%. In only four out of 143 samples, 17OHP could not be quantified accurately, owing to the presence of an interfering chromatographic peak. 6/3-Hydroxyprogesterone was found satisfactory as internal standard. Concentrations of 17OHP in serum of normal men and women, post-menopausal or in follicular phase of their menstrual cycle, were less than 2.5 .tg/L; somewhat higher values 33, 42-46 (1971) . 7. Youseffnejadian, E., Florensa, E., Collins, W. P., and Sommerville, I. F., Radioimmunoassay of 17-hydroxyprogesterone. Steroids 20, 773-788 (1972). 8. Tea, N. T., Castanier, M., Roger, M., and Scholler, R., Simultaneous radioimmunoassay of plasma progesterone and 17-hydroxyprogesterone.
Normal values in children, in men and in women throughout the menstrual cycle and in early pregnancy. J. Steroid Biochem. 6, 1509 Biochem. 6, -1516 Biochem. 6, (1975 . 27, 973-990 (1967) .
Metab
11. Youssefnjadian, E., and David, R., Early diagnosis of congenital adrenal hyperplasia by measurement of 17-hydroxyprogesterone. Gun. Endocrinol. 4, 451-454 (1975 globulin to which 17OHP also is known to be bound (10).
Results obtained for adults and newborns are similar to those reported by other investigators, who used RIA (6-9, 11). In one case with congenital adrenal hyperplasia, we found 17OHP concentrations in cord blood to be about fivefold higher than normal, suggesting that cord blood analysis for 17OHP may be of value in early diagnosis of the disease. However, further studies in this area are necessary.
Although values for 17OHP as obtained by liquid chromatography were somewhat higher than by RIA, results by the two assays correlated well. RIA is a more sensitive method for 17OHP than liquid chromatography, but future developments such as new detectors and the use of gradient systems for the mobile phase should increase the sensitivity of liquid chromatography. The advantages that liquid chromatography offers over other current methods for measurement of 17OHP are its ability to separate and measure the steroid in a single step, its great specificity, and the complete analytical recovery of added 17OHP. In addition, the method is simple, accurate, and capable of also measuring cortisol and 11 -deoxycortisol in the same assay. These other determinations should allow for a better tool in the diagnosis and management of patients with various forms of congenital adrenal hyperplasia.
In conclusion, these studies indicate liquid chromatography to be a useful method for measuring 17OHP in addition to cortisol and 11 -deoxycortisol.
As new refinements of the assay become available, more steroids could be measured simultaneously in a single serum extract, thus increasing the capability, efficiency, and clinical applications of the method.
